Skip to main content

Table 6 hTERT mRNA level in CTCs of NPC patients and its association with clinicopathological factors

From: Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Factor No. hTERT mRNA (2-Ct)(X ± SD) F/t value P value
Clinical stage
 I 4 3.65 ± 1.05 28.95 <0.01
 II 5 7.18 ± 1.44
 III 15 10.97 ± 2.19
 IV 9 15.13 ± 2.92
N Stage
 N0 4 3.65 ± 1.05 16.36 <0.01
 N1 5 7.18 ± 1.44
 N2 17 11.86 ± 3.26
 N3 7 14.17 ± 2.43
T Stage
 T1 11 6.93 ± 3.14 20.83 <0.01
 T2 6 9.25 ± 3.03
 T3 13 12.62 ± 1.78
 T4 3 18.85 ± 1.30